Medical terrorism of US, allies continues to take toll on Iranian EB patients
A Paris-based intergovernmental organization has scandalously turned down a petition against a Swedish pharma company lodged on behalf of Iranians who suffer from a potentially fatal skin disease.
The petition was submitted earlier this year by the lawyer, who represents the patients afflicted with epidermolysis bullosa (EB), a type of disease that causes fragile, blistering skin.
The US sanctions against Iran have been choking up the financial channels that could be used towards providing the Islamic Republic with the cure for EB sufferers and other direly-needed medical supplies.
Washington reinstated the cruel economic sanctions after unilaterally abandoning the 2015 deal between the Islamic Republic and world powers.
The petition had protested the submission of Mölnlycke, a Sweden-headquartered internationally active supplier of medical devices, to the sanctions, which has caused the company to withhold the bandages that are needed by those suffering from the skin condition.
The petition was turned down by the Organization for Economic Cooperation and Development (OECD), of which Sweden is a member, Iranian media outlets reported on Wednesday.
It was tossed out by OECD’s National Contact Point, a mechanism in the member states that supervises multinational enterprises that are headquartered in those states.
Last month, Iranian ambassador to Sweden said Swedish pharmaceutical company keeps halting the supply of special bandages needed to treat Iranian patients suffering from a special skin condition as it continues to comply with American sanctions on Iran.